Live Event

Primary Care Challenges for Todays Practitioner: Practice Strategies for Internal and Family Medicine Specialists

Title:Primary Care Challenges for Todays Practitioner: Practice Strategies for Internal and Family Medicine Specialists
Dates:March 25, 2019 8:00 am - March 29, 2019 12:15 pm
Location:Sarasota, Florida
Daily Schedule:8:00am-12:15pm
Course #:SEMLA-3320190325

Certifications

20 AMA PRA Category 1 Credits™
20 CME Credits – AAFP ACEP ACOG
Mainpro-M1 (Canadian Physicians)

PLEASE CLICK HERE TO BOOK YOUR HOTEL ROOM FOR THIS CONFERENCE


Venue

100 Marina View Drive
Sarasota
Florida
34236
United States

We’re excited to welcome event attendees to the Westin Sarasota, the city’s newest luxury accommodations. Gorgeous sunset views from the rooftop pool and bar, nearby white sand beaches and high-end dining just blocks away are waiting for you.Indulge Your Every Sense at Downtown Sarasota’s Premier New Hotel. Surround yourself with contemporary elegance at The Westin Sarasota.

Overlooking Sarasota Bay, in the midst of the vibrant arts district, our brand new hotel features sophisticated touches designed to make your stay exceptional.Take advantage of the ideal downtown setting and complimentary shuttle to explore the city’s best theater, arts and beaches. Just 10 minutes from the Sarasota-Bradenton International Airport (SRQ).

Join us in Sarasota and stay at the Westin using our booking link below and receive: 

  • a 20% discount on services from The Spa & Salon
  • waived $22 per room per day destination fee 
  • reduced valet parking rate of $15 per night

By staying at the host hotel, not only do you save money, but you help us meet our contractual obligations, thereby, allowing us to keep your future hotel room rates and registration fees reasonable.If you have any problems making your reservations with the Westin Sarasota, please contact our office at 866-267-4263 and we will be happy to assist you.


Course Outline

Day 1

Use and Interpretation of Thyroid Tests.

Upon completion of this session, using the American Thyroid Association Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Integrate the serum tests for thyroid function.
  2. Interpret thyroid tests results that occur in clinical settings.
  3. Recommend the appropriate follow-up testing of abnormal thyroid tests and the frequency of these evaluations.
  4. Appraise the need to treat subclinical hypothyroidism or subclinical hyperthyroidism.

Delirium in the Elderly – Current Concepts.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Specify diagnostic features and common causes of delirium in seniors.
  2. Distinguish the causes of persistent delirium.
  3. Use evidence based medicine to formulate treatment approaches to delirious seniors.
  4. Recognize treatment options for intermittent agitation using evidence based medicine.

Evaluation and Treatment of Hypertensive Patients.

Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP

  1. Employ the non-pharmacologic treatment options to manage hypertension.
  2. Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
  3. Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
  4. Distinguish the side effect risks for each class of antihypertensive medications.

Evaluation and Treatment of Dementia in Seniors. Upon completion of this session, the participant should be able to:          EBM, COMP

  1. Determine the common causes of cognitive dysfunction and dementia in seniors.
  2. Develop an evidence based evaluation of seniors with cognitive dysfunction.
  3. Evaluate the relative risks and benefits of available treatment options for dementia in seniors.
  4. Distinguish the central role of caregiver education and support in treating seniors with dementia.

Day 2

Vitamin B-12 and Vitamin D in Seniors.      

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Integrate the normal physiology of Vitamins B-12 and D.
  2. Differentiate the pathologic syndromes associated with B-12 and D deficiency.
  3. Develop an evidence based evaluation of B-12 and D deficiency for seniors.
  4. Develop an evidence based approach to treatment options for B-12 and D in seniors.

Treating Patients with Type 2 Diabetes Mellitus.

Upon completion of this session, using the American Diabetes Association, the European Association for the Study of Diabetes Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Evaluate the therapeutic goals in treating type 2 diabetes and their impact on morbidity and mortality.
  2. Recommend the approach for choosing an oral hypoglycemic agent to treat type 2 diabetes.
  3. Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c.
  4. Develop the therapeutic options for preventing diabetic complications.

Advanced Nutritional Assessment and Therapy.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Integrate readily available clinical data to make accurate nutritional assessments in seniors.
  2. Relate metabolic changes in aging to assess risk for malnutrition.
  3. Apply an evidence based approach to treatment of undernutrition in seniors.

Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment.

Upon completion of this session, using the ACCP GOLD guidelines, the AACVPR practice guidelines and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP

  1. Appraise patient specific data to determine if they meet diagnostic criteria for COPD.
  2. Analyze the role of cigarette smoking in the etiology and natural history of COPD.
  3. Formulate a treatment plan for the stages of COPD.
  4. Recommend the follow-up required to assess the therapeutic efficacy of the treatment options.

Day 3

Contemporary Issues in End of Life Care.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Develop a practical approach to assessment of the whole patient in a hospice setting.
  2. Formulate effective approaches to common physical symptoms in the terminally ill.
  3. Integrate effective clinical care of patients and their families in the last days of life based on current evidence-based literature, Guidelines and recommendations of the American Geriatrics Society and the National Hospice and Palliative Care Organization.
  4. Relate dementia as a terminal illness.

Improving Communication Skills in Medical Practice.

Upon completion of this session, the participant should be able to: COMP^

  1. Appraise the variety of ways that people perceive communication and process information.
  2. Assess your personal communication strengths and limitations.
  3. Determine communication issues unique to older patients.
  4. Develop practices and apply skills to maximize effective communication and listening based on current literature.

Venous Thromboembolism (VTE): Diagnosis and Treatment.

Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Determine the diagnostic testing for evaluating a patient for possible VTE.
  2. Apply the algorithm for diagnosing a pulmonary embolism in multiple clinical settings.
  3. Differentiate the advantages and disadvantages of outpatient treatment compared to inpatient treatment for venous thromboembolism (VTE).
  4. Order the frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE.

Contraceptive Options – Helping Women Make an Informed Choice.

Upon completion of this session, using the ACOG Practice Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Appraise the pharmacologic differences in oral contraceptives and their role in contraceptive efficacy.
  2. Formulate the treatment options for contraception other than oral contraceptives.
  3. Specify the relative and absolute contraindications to oral contraceptives.
  4. Relate the circumstances that would be eligible for emergency contraception and the appropriate emergency contraception method for each situation.

Day 4

Migraine Headaches – Update on Diagnosis and Treatment.

Upon completion of this session, using the International Headache Society and U.S. Headache Consortium Guidelines and the National Guideline Clearinghouse and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP

  1. Construct the approach for evaluating a patient with possible migraine headaches.
  2. Assess the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy.
  3. Appraise the pharmacologic options for treating the acute pain of a migraine headache.
  4. Recommend a prophylactic therapy regimen for patients with recurrent migraine headaches. 

Outpatient Anticoagulation Issues.

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Manage outpatients on warfarin using current CHEST guidelines and The Joint Commission 2016 National Patient Safety Goals.
  2. Determine factors leading to alterations in the international normalized ratio (INR).
  3. Advise patients on the appropriate choice, duration, and intensity of anticoagulation in a variety of clinical scenarios.
  4. Develop a familiarity with the new oral anticoagulants.

Osteoporosis: Treatment and Prevention.

Upon completion of this session, using the USPSTF, NOF Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Debate the importance of the risk factors for an osteoporosis fracture.
  2. Employ the diagnostic testing for patients at risk with osteoporosis.
  3. Select the therapeutic medication to treat osteoporosis based upon the indications and side effects.
  4. Assess the therapeutic role of repeating the DXA scan in patients treated for osteoporosis.

Peripheral Arterial Disease (PAD) – A Primary Care Perspective. 

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Assess the relationship between PAD and other forms of atherosclerosis.
  2. Determine which patients are at increased risk for PAD.
  3. Perform a focused history and physical examination to assess for PAD.
  4. Determine when to use ancillary testing.

Develop a plan for managing patients with PAD utilizing evidence-based ACC/AHA  and CHEST guidelines for exercise, medications, and revascularization.

Day 5

Evaluation of the Patient with Syncope. 

Upon completion of this session, the participant should be able to: GL, COMP

  1. Appraise the various etiologies of syncope.
  2. Use clues in the history and physical as well as simple office testing to risk stratify patients with syncope.
  3. Develop a plan for appropriate use of additional testing in patients with syncope to include indications for EP testing as per the AHA Syncope Algorithm and the ESC Guidelines.
  4. Assess the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.

Adult Health Screening and Immunizations – Evidence-Based Approach.

Upon completion of this session, using the USPSTF and Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Apply the evidence-based recommendations for preventive screening tests for adults.
  2. Determine the immunizations required for adults.
  3. Appraise the side effects of adult immunizations.
  4. Select the contraindications for each adult immunization and their alternative therapy.
  5. Plan when screening tests can be discontinued in adults.

Drug Interactions and Side Effects. 

Upon completion of this session, the participant should be able to: GL, EBM, COMP

  1. Determine the most common mechanisms for drug interactions.
  2. Identify some of the most frequent culprit drugs such as Warfarin and Acetaminophen, AED’s, NSAIDs, and Statins.
  3. Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
  4. Employ The Joint Commission 2016 Ambulatory Care National Patient Safety Goals.

Evaluation and Initial Management: Benign Breast Disease

Upon completion of this session, using the American Cancer Society Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Differentiate the signs and symptoms associated with benign breast disease.
  2. Formulate an evaluation for breast pain (mastalgia), breast lumps, and nipple discharge.
  3. Specify the treatment options for breast pain, nipple discharge and breast infections.
  4. Distinguish the symptoms and physical findings associated with rare benign breast disease conditions.

Presented By

Presenter

  • Gary H. Oberlender, M.D., F.A.C.P – Senior Evaluations, LLC
  • Herbert L. Muncie, Jr., M.D.
    Professor of Family Medicine, Department of Family Medicine, New Orleans, LA
  • Michael P. Goldfinger, M.D., F.A.C.P. – Drexel University College of Medicine

Fee Structure

To receive the Early Registration Rate, fees must be postmarked >60 days prior to program start date (March 25, 2019 8:00 am).

Register

Details Price Qty
Physician Fees - Early Registration $899.00 (USD)  
Physician Fees - Regular Registration $949.00 (USD)   Goes On Sale
January 25, 2019
Resident Fees - Early Registration $799.00 (USD)  
Resident Fees - Regular Registration $849.00 (USD)   Goes On Sale
January 25, 2019
Advanced Practitioner Fees - Early Registration $749.00 (USD)  
Advanced Practitioner Fees - Regular Registration $799.00 (USD)   Goes On Sale
January 25, 2019
AMS Exception Ticket $899.00 (USD)  

Need help? Have a question?

mail@ams4cme.com 1-866-267-4263 Disclaimer: AMS reserves the right to cancel any conference within 6 weeks of conference date. Registrants will receive a full refund within 7 business days. AMS is not responsible for charges associated with canceled flight or hotel rooms. AMS Cancellation Policy: Although it is rarely necessary, American Medical Seminars, Inc. reserves the right to modify speakers and subject matter. American Medical Seminars, Inc. assumes no liability beyond the refund of the seminar registration fee. In the unlikely event that AMS postpones or cancels this conference due to circumstances beyond our control, you will be provided with a refund for the registration fee or you can opt to transfer to another of our live events.